Report cover image

North America Pterygium Drug Market - Industry Trends and Forecast to 2029

Publisher Data Bridge Market Research
Published Oct 01, 2022
Length 140 Pages
SKU # DAABD17480602

Description

North America Pterygium Drug Market - Industry Trends and Forecast to 2029

The North America pterygium drug market is projected to register a substantial CAGR of 5.8% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2020, the base year of calculation is 2021, and the forecast period is 2022 to 2029.

Market Segmentation

North America Pterygium Drug Market, By Type (Progressive Pterygium and Atrophic Pterygium), Stages (Stage 2, Stage 3, Stage 1), Treatment (Artificial Tears/Topical Lubricants and Steroid Eye Drops.), Formulation (Eye Drops, Eye Ointments, Others), Mode of Purchase (Prescription and Over the Counter (OTC)), Population Type (Geriatric and Adults), End User (Hospitals, Specialty Clinics, Home Healthcare, Others), Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, Others), Country (U.S., Canada, Mexico) Industry Trends and Forecast to 2029.

Some of the major factors contributing to the growth of North America pterygium drug market are:
• Increase in healthcare awareness to reduce the risk of eye illnesses
• Rising geriatric population

Market Players

Some of the major players operating in the North America pterygium drug market are:
• Johnson & Johnson Services, Inc.
• Novartis AG
• Akorn Operating Company LLC
• Bausch & Lomb Incorporated
• AbbVie Inc.
• Prestige Consumer Healthcare Inc.
• Bayer AG
• Zydus Group
• Amneal Pharmaceuticals LLC
• OASIS Medical
• Alcon
• Santen Pharmaceutical Co.Companies

• Johnson & Johnson Services, Inc.
• Novartis AG
• Akorn Operating Company LLC
• Bausch & Lomb Incorporated
• AbbVie Inc.
• Prestige Consumer Healthcare Inc.
• Bayer AG
• Zydus Group
• Amneal Pharmaceuticals LLC
• OASIS Medical
• Alcon
• Santen Pharmaceutical Co.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.

Table of Contents

140 Pages
1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Overview Of North America Pterygium Drug Market
1.4 Currency And Pricing
1.5 Limitations
1.6 Markets Covered
2 North America Pterygium Drug Market: Segmentation
2.1 Markets Covered
2.2 Geographical Scope
2.3 Years Considered For The Study
2.4 Dbmr Tripod Data Validation Model
2.5 Primary Interviews With Key Opinion Leaders
2.6 Multivariate Modelling
2.7 Class Segment Lifeline Curve
2.8 Dbmr Market Position Grid
2.9 Vendor Share Analysis
2.10 Market End User Coverage Grid
2.11 Secondary Sources
3 Executive Summary
4 Premium Insights
4.1 Pestel's Model
4.2 Porter's 5 Forces
4.3 Epidemiology
4.4 North-america Pterygium Drug Market: Number Of Surgeries
5 Pipeline Analysis
6 North-america Pterygium Drug Market: Regulations
6.1 Regulation In The North-america
7 Market Overview
7.1 Drivers
7.1.1 Rise In Incidences And Prevalence Of Ophthalmic Disorders
7.1.2 Rise In Geriatric Population
7.1.3 Increase In Healthcare Awareness To Reduce The Risk Of Eye Illnesses
7.2 Restraints
7.2.1 High Cost Of Eye Treatment And Medication
7.2.2 Side Effects Of Steroids Eye Drops
7.3 Opportunities
7.3.1 Programs And Initiatives To Reduce The Burden Of Eye Diseases
7.3.2 Rise In Healthcare Expenditure And Disposable Income
7.3.3 Increase In Research And Development Activities
7.4 Challenges
7.4.1 Stringent Rules & Regulations
7.4.2 Exposure To Ultraviolet Radiations
8 North America Pterygium Drug Market, By Disease Type
8.1 Overview
8.2 Progressive Pterygium
8.3 Atrophic Pterygium
9 North America Pterygium Drug Market, By Stages
9.1 Overview
9.2 Stage 2
9.3 Stage 3
9.4 Stage 1
10 North America Pterygium Drug Market, By Treatment
10.1 Overview
10.2 Artificial Tears/Topical Lubricants
10.2.1 Demulcent
10.2.2 Emollients
10.3 Steroid Eye Drops
10.3.1 Ketone Steroids
10.3.1.1 Prednosolone
10.3.1.2 Dexamethasone
10.3.1.3 Flurometholone
10.3.1.4 Others
10.3.2 Ester Steroid (Loterprednol)
11 North America Pterygium Drug Market, By Formulation
11.1 Overview
11.2 Eye Drops
11.2.1 Eye Drops With Preservatives
11.2.2 Preservative-free Eye Drops
11.3 Eye Ointments
11.4 Others
12 North America Pterygium Drug Market, By Mode Of Purchase
12.1 Overview
12.2 Prescription
12.3 Over The Counter (Otc)
13 North America Pterygium Drug Market, By Population Type
13.1 Overview
13.2 Geriatric
13.3 Adults
14 North America Pterygium Drug Market, By End User
14.1 Overview
14.2 Hospitals
14.3 Specialty Clinics
14.4 Home Healthcare
14.5 Others
15 North America Pterygium Drug Market, By Distribution Channel
15.1 Overview
15.2 Retail Pharmacies
15.3 Hospital Pharmacies
15.4 Online Pharmacies
15.5 Others
16 North America Pterygium Drug Market, By Country
16.1 U.S.
16.2 Mexico
16.3 Canada
17 North America Pterygium Drug Market: Company Landscape
17.1 Company Share Analysis: North America
18 Swot Analysis
19 Company Profile
19.1 Alcon
19.1.1 Company Snapshot
19.1.2 Recent Financials
19.1.3 Product Portfolio
19.1.4 Recent Developments
19.2 Abbvie Inc.
19.2.1 Company Snapshot
19.2.2 Revenue Analysis
19.2.3 Product Portfolio
19.2.4 Recent Development
19.3 Bausch & Lomb Incorporated
19.3.1 Company Snapshot
19.3.2 Revenue Analysis
19.3.3 Product Portfolio
19.3.4 Recent Development
19.4 Johnson & Johnson Services, Inc.
19.4.1 Company Snapshot
19.4.2 Revenue Analysis
19.4.3 Product Portfolio
19.4.4 Recent Developments
19.5 Bayer Ag
19.5.1 Company Snapshot
19.5.2 Revenue Analysis
19.5.3 Product Portfolio
19.5.4 Recent Developments
19.6 Akorn Operating Company Llc
19.6.1 Company Snapshot
19.6.2 Product Portfolio
19.6.3 Recent Development
19.7 Amneal Pharmaceuticals Llc.
19.7.1 Company Snapshot
19.7.2 Revenue Analysis
19.7.3 Product Portfolio
19.7.4 Recent Developments
19.8 Novartis Ag
19.8.1 Company Snapshot
19.8.2 Revenue Analysis
19.8.3 Product Portfolio
19.8.4 Recent Developments
19.9 Oasis Medical
19.9.1 Company Snapshot
19.9.2 Product Portfolio
19.9.3 Recent Developments
19.10 Prestige Consumer Healthcare Inc.
19.10.1 Company Snapshot
19.10.2 Revenue Analysis
19.10.3 Product Portfolio
19.10.4 Recent Development
19.11 Santen Pharmaceutical Co., Ltd.
19.11.1 Company Snapshot
19.11.2 Recent Financials
19.11.3 Product Portfolio
19.11.4 Recent Development
19.12 Similasan Corporation
19.12.1 Company Snapshot
19.12.2 Product Portfolio
19.12.3 Recent Developments
19.13 Théa Laboratories
19.13.1 Company Snapshot
19.13.2 Product Portfolio
19.13.3 Recent Developments
19.14 Wellona Pharma
19.14.1 Company Snapshot
19.14.2 Product Portfolio
19.14.3 Recent Developments
19.15 Zydus Group
19.15.1 Company Snapshot
19.15.2 Revenue Analysis
19.15.3 Product Portfolio
19.15.4 Recent Developments
20 Questionnaire
21 Related Reports 140
List Of Tables
Table 1 North-america Pterygium Drug Market, Pipeline Analysis
Table 2 North America Pterygium Drug Market, By Disease Type, 2020-2029 (Usd Million)
Table 3 North America Pterygium Drug Market, By Stages, 2020-2029 (Usd Million)
Table 4 North America Pterygium Drug Market, By Treatment, 2020-2029 (Usd Million)
Table 5 North America Artificial Tears/Topical Lubricants In Pterygium Drug Market, By Type, 2020-2029 (Usd Million)
Table 6 North America Steroid Eye Drops In Pterygium Drug Market, By Type, 2020-2029 (Usd Million)
Table 7 North America Ketone Steroids In Pterygium Drug Market, By Type, 2020-2029 (Usd Million)
Table 8 North America Pterygium Drug Market, By Formulation, 2020-2029 (Usd Million)
Table 9 North America Eye Drops In Pterygium Drug Market, By Formulation, 2020-2029 (Usd Million)
Table 10 North America Pterygium Drug Market, By Mode Of Purchase, 2020-2029 (Usd Million)
Table 11 North America Pterygium Drug Market, By Population Type, 2020-2029 (Usd Million)
Table 12 North America Pterygium Drug Market, By End User, 2020-2029 (Usd Million)
Table 13 North America Pterygium Drug Market, By Distribution Channel, 2020-2029 (Usd Million)
Table 14 North America Pterygium Drug Market, By Country, 2020-2029 (Usd Million)
Table 15 U.S. Pterygium Drug Market, By Disease Type, 2020-2029 (Usd Million)
Table 16 U.S. Pterygium Drug Market, By Stages, 2020-2029 (Usd Million)
Table 17 U.S. Pterygium Drug Market, By Treatment, 2020-2029 (Usd Million)
Table 18 U.S. Artificial Tears/Topical Lubricants In Pterygium Drug Market, By Type, 2020-2029 (Usd Million)
Table 19 U.S. Steroids Eye Drops In Pterygium Drug Market, By Type, 2020-2029 (Usd Million)
Table 20 U.S. Ketone Steroids In Pterygium Drug Market, By Type, 2020-2029 (Usd Million)
Table 21 U.S. Pterygium Drug Market, By Formulation, 2020-2029 (Usd Million)
Table 22 U.S. Eye Drops In Pterygium Drug Market, By Formulation, 2020-2029 (Usd Million)
Table 23 U.S. Pterygium Drug Market, By Mode Of Purchase, 2020-2029 (Usd Million)
Table 24 U.S. Pterygium Drug Market, By Population Type, 2020-2029 (Usd Million)
Table 25 U.S. Pterygium Drug Market, By End User, 2020-2029 (Usd Million)
Table 26 U.S. Pterygium Drug Market, By Distribution Channel, 2020-2029 (Usd Million)
Table 27 Mexico Pterygium Drug Market, By Disease Type, 2020-2029 (Usd Million)
Table 28 Mexico Pterygium Drug Market, By Stages, 2020-2029 (Usd Million)
Table 29 Mexico Pterygium Drug Market, By Treatment, 2020-2029 (Usd Million)
Table 30 Mexico Artificial Tears/Topical Lubricants In Pterygium Drug Market, By Type, 2020-2029 (Usd Million)
Table 31 Mexico Steroids Eye Drops In Pterygium Drug Market, By Type, 2020-2029 (Usd Million)
Table 32 Mexico Ketone Steroids In Pterygium Drug Market, By Type, 2020-2029 (Usd Million)
Table 33 Mexico Pterygium Drug Market, By Formulation, 2020-2029 (Usd Million)
Table 34 Mexico Eye Drops In Pterygium Drug Market, By Formulation, 2020-2029 (Usd Million)
Table 35 Mexico Pterygium Drug Market, By Mode Of Purchase, 2020-2029 (Usd Million)
Table 36 Mexico Pterygium Drug Market, By Population Type, 2020-2029 (Usd Million)
Table 37 Mexico Pterygium Drug Market, By End User, 2020-2029 (Usd Million)
Table 38 Mexico Pterygium Drug Market, By Distribution Channel, 2020-2029 (Usd Million)
Table 39 Canada Pterygium Drug Market, By Disease Type, 2020-2029 (Usd Million)
Table 40 Canada Pterygium Drug Market, By Stages, 2020-2029 (Usd Million)
Table 41 Canada Pterygium Drug Market, By Treatment, 2020-2029 (Usd Million)
Table 42 Canada Artificial Tears/Topical Lubricants In Pterygium Drug Market, By Type, 2020-2029 (Usd Million)
Table 43 Canada Steroids Eye Drops In Pterygium Drug Market, By Type, 2020-2029 (Usd Million)
Table 44 Canada Ketone Steroids In Pterygium Drug Market, By Type, 2020-2029 (Usd Million)
Table 45 Canada Pterygium Drug Market, By Formulation, 2020-2029 (Usd Million)
Table 46 Canada Eye Drops In Pterygium Drug Market, By Formulation, 2020-2029 (Usd Million)
Table 47 Canada Pterygium Drug Market, By Mode Of Purchase, 2020-2029 (Usd Million)
Table 48 Canada Pterygium Drug Market, By Population Type, 2020-2029 (Usd Million)
Table 49 Canada Pterygium Drug Market, By End User, 2020-2029 (Usd Million)
Table 50 Canada Pterygium Drug Market, By Distribution Channel, 2020-2029 (Usd Million)
List Of Figures
Figure 1 North America Pterygium Drug Market: Segmentation
Figure 2 North America Pterygium Drug Market: Data Triangulation
Figure 3 North America Pterygium Drug Market: Droc Analysis
Figure 4 North America Pterygium Drug Market: North America Vs Regional Market Analysis
Figure 5 North America Pterygium Drug Market: Company Research Analysis
Figure 6 North America Pterygium Drug Market: Interview Demographics
Figure 7 North America Pterygium Drug Market: Dbmr Position Grid
Figure 8 North America Pterygium Drug Market: Vendor Share Analysis
Figure 9 North America Pterygium Drug Market: End User Coverage Grid
Figure 10 North America Pterygium Drug Market: Segmentation
Figure 11 Increasing Prevalence Of Ophthalmic Disorders And Rise In Geriatric Population Are Expected To Drive The North America Pterygium Drug Market From 2022 To 2029
Figure 12 Progressive Pterygium Is Expected To Have The Largest Share Of The North America Pterygium Drug Market From 2022 & 2029
Figure 13 Drivers, Restraints, Opportunities, And Challenges Of The North-america Pterygium Drug Market
Figure 14 North America Pterygium Drug Market: By Disease Type, 2021
Figure 15 North America Pterygium Drug Market: By Disease Type, 2022-2029 (Usd Million)
Figure 16 North America Pterygium Drug Market: By Disease Type, Cagr (2022-2029)
Figure 17 North America Pterygium Drug Market: By Disease Type, Lifeline Curve
Figure 18 North America Pterygium Drug Market: By Stages, 2021
Figure 19 North America Pterygium Drug Market: By Stages, 2022-2029 (Usd Million)
Figure 20 North America Pterygium Drug Market: By Stages, Cagr (2022-2029)
Figure 21 North America Pterygium Drug Market: By Stages, Lifeline Curve
Figure 22 North America Pterygium Drug Market: By Treatment, 2021
Figure 23 North America Pterygium Drug Market: By Treatment, 2022-2029 (Usd Million)
Figure 24 North America Pterygium Drug Market: By Treatment, Cagr (2022-2029)
Figure 25 North America Pterygium Drug Market: By Treatment, Lifeline Curve
Figure 26 North America Pterygium Drug Market: By Formulation, 2021
Figure 27 North America Pterygium Drug Market: By Formulation, 2022-2029 (Usd Million)
Figure 28 North America Pterygium Drug Market: By Formulation, Cagr (2022-2029)
Figure 29 North America Pterygium Drug Market: By Formulation, Lifeline Curve
Figure 30 North America Pterygium Drug Market: By Mode Of Purchase, 2021
Figure 31 North America Pterygium Drug Market: By Mode Of Purchase, 2022-2029 (Usd Million)
Figure 32 North America Pterygium Drug Market: By Mode Of Purchase, Cagr (2022-2029)
Figure 33 North America Pterygium Drug Market: By Mode Of Purchase, Lifeline Curve
Figure 34 North America Pterygium Drug Market: By Population Type, 2021
Figure 35 North America Pterygium Drug Market: By Population Type, 2022-2029 (Usd Million)
Figure 36 North America Pterygium Drug Market: By Population Type, Cagr (2022-2029)
Figure 37 North America Pterygium Drug Market: By Population Type, Lifeline Curve
Figure 38 North America Pterygium Drug Market: By End User, 2021
Figure 39 North America Pterygium Drug Market: By End User, 2022-2029 (Usd Million)
Figure 40 North America Pterygium Drug Market: By End User, Cagr (2022-2029)
Figure 41 North America Pterygium Drug Market: By End User, Lifeline Curve
Figure 42 North America Pterygium Drug Market: By Distribution Channel, 2021
Figure 43 North America Pterygium Drug Market: By Distribution Channel, 2022-2029 (Usd Million)
Figure 44 North America Pterygium Drug Market: By Distribution Channel, Cagr (2022-2029)
Figure 45 North America Pterygium Drug Market: By Distribution Channel, Lifeline Curve
Figure 46 North America Pterygium Drug Market: Snapshot (2021)
Figure 47 North America Pterygium Drug Market: By Country (2021)
Figure 48 North America Pterygium Drug Market: By Country (2022 & 2029)
Figure 49 North America Pterygium Drug Market: By Country (2021 & 2029)
Figure 50 North America Pterygium Drug Market: By Disease Type (2022-2029)
Figure 51 North America Pterygium Drug Market: Company Share 2021 (%) 107

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us